Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Simons BC"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals.
Autorzy:
Townshend-Bulson L; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Roik E; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Barbour Y; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Bruden DJT; Centers for Disease Control and Prevention, Anchorage, Alaska, United States of America.
Homan CE; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Espera HGF; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Stevenson TJ; Alaska State Virology Laboratory, Anchorage, Alaska, United States of America.
Hewitt AM; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Rhodes W; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Gove JE; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Plotnik JN; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Snowball MM; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
McGilvray J; Pharmacy Department, Southcentral Foundation, Anchorage, Alaska, United States of America.
Simons BC; Centers for Disease Control and Prevention, Anchorage, Alaska, United States of America.
Johnston JM; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
McMahon BJ; Alaska Native Tribal Health Consortium, Liver Disease and Hepatitis Program, Anchorage, Alaska, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2021 Dec 02; Vol. 16 (12), pp. e0260970. Date of Electronic Publication: 2021 Dec 02 (Print Publication: 2021).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antiviral Agents/*therapeutic use
Benzimidazoles/*therapeutic use
Carbamates/*therapeutic use
Fluorenes/*therapeutic use
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Heterocyclic Compounds, 4 or More Rings/*therapeutic use
Sofosbuvir/*therapeutic use
American Indian or Alaska Native/*statistics & numerical data
Adult ; Aged ; Alaska/epidemiology ; Drug Combinations ; Female ; Follow-Up Studies ; Hepacivirus/isolation & purification ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged ; Prognosis ; Sustained Virologic Response
Czasopismo naukowe
Tytuł:
Observed Changes in Natural Killer and T cell Phenotypes with Evaluation of Immune Outcome in a Longitudinal Cohort Following Sofosbuvir -Based Therapy for Chronic Hepatitis C Infection.
Autorzy:
Stevenson TJ; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Barbour Y; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
McMahon BJ; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Townshend-Bulson L; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Hewitt AM; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Espera HGF; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Homan C; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Holck P; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Luna SV; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.
Knall C; WWAMI (Washington, Wyoming, Alaska, Montana, and Idaho) School of Medical Education, University of Alaska, Anchorage.
Simons BC; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage.; WWAMI (Washington, Wyoming, Alaska, Montana, and Idaho) School of Medical Education, University of Alaska, Anchorage.
Pokaż więcej
Źródło:
Open forum infectious diseases [Open Forum Infect Dis] 2019 May 17; Vol. 6 (6), pp. ofz223. Date of Electronic Publication: 2019 May 17 (Print Publication: 2019).
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
Nested case-control study: hepatocellular carcinoma risk after hepatitis B surface antigen seroclearance.
Autorzy:
Gounder PP; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.
Bulkow LR; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.
Snowball M; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Negus S; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Spradling PR; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, USA.
Simons BC; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
McMahon BJ; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention (CDC), Anchorage, AK, USA.; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2016 Jun; Vol. 43 (11), pp. 1197-207. Date of Electronic Publication: 2016 Apr 08.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Hepatocellular/*epidemiology
Hepatitis B virus/*genetics
Hepatitis B, Chronic/*complications
Liver Neoplasms/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Child ; Child, Preschool ; Female ; Hepatitis B Surface Antigens/immunology ; Hepatitis B e Antigens ; Humans ; Infant ; Male ; Middle Aged ; Proportional Hazards Models ; Risk ; Young Adult
Czasopismo naukowe
Tytuł:
Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C.
Autorzy:
Livingston SE; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Townshend-Bulson LJ; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Bruden DJ; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA.
Homan CE; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Gove JE; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Plotnik JN; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Simons BC; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.
Spradling PR; Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
McMahon BJ; Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, AK, USA.; Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK, USA; .
Pokaż więcej
Źródło:
International journal of circumpolar health [Int J Circumpolar Health] 2016 Mar 29; Vol. 75, pp. 30696. Date of Electronic Publication: 2016 Mar 29 (Print Publication: 2016).
Typ publikacji:
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Hepacivirus/*drug effects
Hepatitis C, Chronic/*drug therapy
Interferon-alpha/*administration & dosage
Polyethylene Glycols/*administration & dosage
Ribavirin/*administration & dosage
Adult ; Aged ; Alaska ; Alaska Natives/statistics & numerical data ; Antiviral Agents/therapeutic use ; Drug Therapy, Combination ; Female ; Follow-Up Studies ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/epidemiology ; Humans ; Indians, North American/statistics & numerical data ; Longitudinal Studies ; Male ; Middle Aged ; Recombinant Proteins/administration & dosage ; Risk Assessment ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Alaska Native and rural youth views of sexual health: a focus group project on sexually transmitted diseases, HIV/AIDS, and unplanned pregnancy.
Autorzy:
Leston JD; />Jessen CM
Simons BC
Pokaż więcej
Źródło:
American Indian and Alaska native mental health research (Online) [Am Indian Alsk Native Ment Health Res] 2012; Vol. 19 (1), pp. 1-14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*
Health Knowledge, Attitudes, Practice*
Pregnancy, Unplanned*
Sexually Transmitted Diseases*
Adolescent ; Alaska ; Condoms ; Female ; Focus Groups ; Humans ; Indians, North American ; Male ; Pregnancy ; Qualitative Research ; Rural Population ; Young Adult
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies